Next Level Private’s iShares Biotechnology ETF IBB Stock Holding History

Next Level Private’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Hold	1,193	–	–	0.04%	163
2026 Q1	$201K	Buy	1,193 +1	+0.1%	+$171	0.05%	171
2025 Q4	$201K	Buy	+1,192	New	+$194K	0.05%	158
2022 Q3	–	Sell	-3,021	Closed	-$355K	–	117
2022 Q2	$355K	Buy	+3,021	New	+$359K	0.14%	109

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Next Level Private's IBB Position: Q2 2026 in Review

Next Level Private held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,193 shares worth $227K. The position accounts for 0.04% of the portfolio, ranked #163.

Next Level Private first reported a position in IBB in Q2 2022 and has held it in 4 quarters since. The position peaked at $355K in Q2 2022. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Next Level Private held 1,193 shares of iShares Biotechnology ETF worth $227K as of Q2 2026.
Next Level Private left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.04% of Next Level Private's portfolio in Q2 2026, its #163 holding.
Next Level Private first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 4 quarters since.
Next Level Private's iShares Biotechnology ETF position peaked at $355K in Q2 2022.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Next Level Private's 13F filing for Q2 2026, filed 9 Jul 2026.